NIHR invests £55m to tackle health inequalities and outcomes
Millions of people in the UK are set to benefit from the second wave of funding
Read More
Tag: Health Determinants Research Collaborations
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
